1. Adelstein DJ, Saxton JP, Rybicki LA et al (2008) Concurrent chemoradiotherapy and gefitinib for locoregionally advanced head and neck squamous cell cancer. Presented at the 7th International Conference on head and neck cancer, San Francisco, CA, Abstr S198
2. Ahmed SM, Cohen EE, Haraf DJ et al (2007) Updated results of phase II trial integrating gefitinib (G.) into concurrent chemoradiation (CRT) followed by G. adjuvant therapy for locally advanced head and neck cancer (HNC). ASCO Meet Abstr 6028
3. Ahsan A, Hiniker SM, Davis MA et al (2009) Role of cell cycle in epidermal growth factor receptor inhibitor-mediated radiosensitization. Cancer Res 69:5108–14
4. Akimoto T, Hunter NR, Buchmiller L et al (1999) Inverse relationship between epidermal growth factor receptor expression and radiocurability of murine carcinomas. Clin Cancer Res 5:2884–90
5. Akita RW, Sliwkowski MX (2003) Preclinical studies with erlotinib (Tarceva). Semin Oncol 30:15–24